CA1066189A - Preparation d'un produit contenant le facteur antihemophilique, qui passe rapidement en solution - Google Patents

Preparation d'un produit contenant le facteur antihemophilique, qui passe rapidement en solution

Info

Publication number
CA1066189A
CA1066189A CA268,228A CA268228A CA1066189A CA 1066189 A CA1066189 A CA 1066189A CA 268228 A CA268228 A CA 268228A CA 1066189 A CA1066189 A CA 1066189A
Authority
CA
Canada
Prior art keywords
composition
ahf
carbohydrate
amount
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA268,228A
Other languages
English (en)
Inventor
William R. Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Travenol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/729,758 external-priority patent/US4089944A/en
Application filed by Baxter Travenol Laboratories Inc filed Critical Baxter Travenol Laboratories Inc
Application granted granted Critical
Publication of CA1066189A publication Critical patent/CA1066189A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA268,228A 1975-12-22 1976-12-20 Preparation d'un produit contenant le facteur antihemophilique, qui passe rapidement en solution Expired CA1066189A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64317875A 1975-12-22 1975-12-22
US05/729,758 US4089944A (en) 1975-12-22 1976-10-05 Rapidly solubilized AHF composition and process for preparing same

Publications (1)

Publication Number Publication Date
CA1066189A true CA1066189A (fr) 1979-11-13

Family

ID=27094202

Family Applications (1)

Application Number Title Priority Date Filing Date
CA268,228A Expired CA1066189A (fr) 1975-12-22 1976-12-20 Preparation d'un produit contenant le facteur antihemophilique, qui passe rapidement en solution

Country Status (7)

Country Link
JP (1) JPS5282716A (fr)
AT (1) AT351158B (fr)
CA (1) CA1066189A (fr)
DE (1) DE2653534C2 (fr)
ES (1) ES454453A1 (fr)
GB (1) GB1540610A (fr)
MX (1) MX4730E (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
HUP9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2826533A (en) * 1954-03-15 1958-03-11 Cutter Lab Stable fibrinogen solutions and method for producing same

Also Published As

Publication number Publication date
ES454453A1 (es) 1978-04-01
DE2653534A1 (de) 1977-06-30
GB1540610A (en) 1979-02-14
ATA956676A (de) 1978-12-15
DE2653534C2 (de) 1986-08-28
AT351158B (de) 1979-07-10
JPS5282716A (en) 1977-07-11
MX4730E (es) 1982-08-24

Similar Documents

Publication Publication Date Title
US4089944A (en) Rapidly solubilized AHF composition and process for preparing same
US4478829A (en) Pharmaceutical preparation containing purified fibronectin
DE3400413C2 (fr)
DE69432179T3 (de) Eine formulierung des gerinnungsfaktors viii
DE69531204T2 (de) Formulierungen fuer faktor ix
DE69333928T2 (de) Verbesserte solubilisierung und stabilisierung des faktor viii-komplexes
EP0796623B1 (fr) Préparation pharmaceutique pour le traitement des maladies de la coagulation sanguine
EP0627924B1 (fr) Composition comprenant une formulation d'un facteur de coagulation viii, procede pour sa preparation et utilisation d'un agent tensioactif comme stabilisateur
CA1248453A (fr) Composes pharmaceutiques contenant des glycosides de l'anthracycline
US3631018A (en) Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
EP0733702B1 (fr) Préparations stables de transglutaminase et procédé de leur préparation
JP2818898B2 (ja) 活性に鋭敏な人のプロテインから成る装薬を作用物質として備えている双室注射器
JPS597693B2 (ja) 抗トロンビン製剤及びその製法
DE69029765T2 (de) Stabilisierung von hochgereinigten Proteinen
DE69630291T2 (de) Proteinformulierung, die koajulationsfehler viii oder ix in einer saccharose wässriger lösung enthält
EP0302754A2 (fr) Solution aqueuse stable de thrombine
HU202761B (en) Process for producing stabilized erythropoietin compositions
EP2258402A2 (fr) Composition sèche
US4168303A (en) Lyophilized native gamma globulin preparation for intravenous administration
US4085095A (en) Clottable fibrinogen free Factor VIII product and process
CH664495A5 (de) Pharmazeutische formulierung.
IL172844A (en) Process for obtaining cryoprecipitable proteins including a virus inactivation step
US3933996A (en) Composition comprising radioactive labeled-fibrinogen and albumin
CH665356A5 (de) Pharmazeutische formulierung.
EP0124018B1 (fr) Préparation pharmaceutique contenant de la fibrinonectine purifiée